Chemotherapy Clinical Trial
Official title:
Appropriateness of Replacing Fluoroscopic Guidance by ECG Guidance in PICC Insertion, RCT
The aim of this study is to compare two techniques of placing a peripherally inserted central venous catheter (PICC). The first technique, uses ECG based electromagnetic guidance (ECG-EM). The second (reference technique), is guided by X-ray (fluoroscopy).
The method of placement under fluoroscopic control (FX) is considered as the reference
technique. This is often criticized for disadvantages such as costs, logistical problems and
relative ionizing radiation. Despite this, it is still advised by 75% of PICC providers.
Appeared about ten years ago, a per procedural guiding technique with intracavitary ECG
tracking (ECG-EM) presents a better technical success (precision and specificity) than the
blind technique, but there is still a lack in comparing this technique to the FX technique.
This prospective randomized controlled study is designed to compare the PICC insertion using
ECG-EM guidance to fluoroscopic (FX) guidance in order to define whether a replacement of the
FX technique by ECG-EM is appropriate in terms of the final catheter tip position of the PICC
as well as length of the outgoing catheter at the entry point.
All included patients gave their written consent and the study is approved by EC.
Participation is open to all adults referred to the radiology department of the CHUV for
insertion of a PICC (monocentric).
Recruited patients will be randomly assigned to one of the two arms (FX or ECG-EM).
For both procedures patient position and preparation (MSB, maximal sterile barrier) are
standardized and are similar.
FX method consists on a puncture of an arm vein, under the ultrasound control and local
anesthesia. Through the point of puncture, a long wire is then introduced and directed to the
level of the target zone located in the superior vena cava under fluoroscopy control. The
length of the guide inside the vessel is then measured to adjust the length of the PICC
necessary for its optimal positioning.
For ECG-EM insertion technique, the vein puncture is done in similar conditions to the FX
method. The length of the PICC is estimated prior to its insertion using morphological
landmarks. The placement of the PICC is done using SHERLOCK 3CG™ Diamond Tip Confirmation
System (TCS) (CE marked device; C. R. Bard, Inc.).
At the end of procedure, a chest x-ray is performed to assess the PICC position. Possible
per-procedural complications are documented.
After intervention, the patient is transferred back to the ward or sent home in stable
conditions.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05856656 -
Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer
|
N/A | |
Active, not recruiting |
NCT02959541 -
PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
|
N/A | |
Completed |
NCT00757094 -
Safety and Feasibility of Fasting While Receiving Chemotherapy
|
N/A | |
Recruiting |
NCT00797238 -
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
|
N/A | |
Not yet recruiting |
NCT05927857 -
Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .
|
Phase 1/Phase 2 | |
Recruiting |
NCT04453826 -
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
|
Phase 3 | |
Completed |
NCT04466332 -
Comparison of Two ECG Guided PICC Insertion Techniques
|
N/A | |
Not yet recruiting |
NCT04055038 -
Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)
|
Phase 2/Phase 3 | |
Recruiting |
NCT03701607 -
Effect of Chemotherapy on PD-L1 in NSCLC
|
||
Recruiting |
NCT04024241 -
Medium Dose of Cytarabine and Mitoxantrone
|
||
Recruiting |
NCT06208436 -
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
|
||
Recruiting |
NCT05306301 -
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
|
Phase 2 | |
Active, not recruiting |
NCT02304640 -
Prevalence, Severity and Determinants of Cancer-related Fatigue (CRF) in Asian Breast Cancer Patients
|
||
Completed |
NCT02298972 -
Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer
|
N/A | |
Terminated |
NCT01249001 -
Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents
|
Phase 2 | |
Recruiting |
NCT03089892 -
A Perspective Study of Cancer-related Fatigue in Gynecologic Cancer Patients Under Chemotherapy
|
N/A | |
Recruiting |
NCT05125055 -
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
|
Phase 2/Phase 3 | |
Recruiting |
NCT04472403 -
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
|
||
Terminated |
NCT02982694 -
Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer
|
Phase 2 | |
Completed |
NCT03261128 -
Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)
|